Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian A Costello

Showing results (21-30 of 118) with videos related to

Pageof 12
Sort By:
Clinical Genitourinary Cancer|December 8, 2021
Thoracic Radiotherapy for Renal Cell Carcinoma Metastases: Local Control for the Management of Lung and Mediastinal Disease in the Modern EraGlenn A Stewart, William G Breen, Bradley J Stish, et al.
The Journal of Urology|April 19, 2011
Independent validation of the 2010 American Joint Committee on Cancer TNM classification for renal cell carcinoma: results from a large, single institution cohortSimon P Kim, Angela L Alt, Christopher J Weight, et al.
BJU International|July 14, 2016
Germline genetic variation in JAK2 as a prognostic marker in castration-resistant prostate cancerBen Y Zhang, Shaun M Riska, Douglas W Mahoney, et al.
International Journal of Radiation Oncology, Biology, Physics|July 25, 2022
Radiation Therapy in Oligometastatic Prostate CancerSiven Chinniah, Bradley Stish, Brian A Costello, et al.
The Journal of Urology|January 29, 2013
Association of microvascular and capillary-lymphatic invasion with outcome in patients with renal cell carcinomaManuel S Eisenberg, John C Cheville, R Houston Thompson, et al.
European Urology|June 6, 2015
Comprehensive Characterization of the Perioperative Morbidity of Cytoreductive NephrectomyBoris Gershman, Daniel M Moreira, Stephen A Boorjian, et al.
The Journal of Urology|March 26, 2018
Comparative Survival following Initial Cytoreductive Nephrectomy versus Initial Targeted Therapy for Metastatic Renal Cell CarcinomaBimal Bhindi, Elizabeth B Habermann, Ross J Mason, et al.
European Urology|January 18, 2017
Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical ResectionBoris Gershman, Daniel M Moreira, R Houston Thompson, et al.
European Urology|November 15, 2017
Perioperative Morbidity of Lymph Node Dissection for Renal Cell Carcinoma: A Propensity Score-based AnalysisBoris Gershman, Daniel M Moreira, R Houston Thompson, et al.
The Journal of Urology|September 25, 2016
Lymph Node Dissection is Not Associated with Improved Survival among Patients Undergoing Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: A Propensity Score Based AnalysisBoris Gershman, R Houston Thompson, Daniel M Moreira, et al.
Pageof 12

Showing results (21-30 of 118) with videos related to

Sort By:
Pageof 12
Clinical Genitourinary Cancer|December 8, 2021
Thoracic Radiotherapy for Renal Cell Carcinoma Metastases: Local Control for the Management of Lung and Mediastinal Disease in the Modern EraGlenn A Stewart, William G Breen, Bradley J Stish, et al.
The Journal of Urology|April 19, 2011
Independent validation of the 2010 American Joint Committee on Cancer TNM classification for renal cell carcinoma: results from a large, single institution cohortSimon P Kim, Angela L Alt, Christopher J Weight, et al.
BJU International|July 14, 2016
Germline genetic variation in JAK2 as a prognostic marker in castration-resistant prostate cancerBen Y Zhang, Shaun M Riska, Douglas W Mahoney, et al.
International Journal of Radiation Oncology, Biology, Physics|July 25, 2022
Radiation Therapy in Oligometastatic Prostate CancerSiven Chinniah, Bradley Stish, Brian A Costello, et al.
The Journal of Urology|January 29, 2013
Association of microvascular and capillary-lymphatic invasion with outcome in patients with renal cell carcinomaManuel S Eisenberg, John C Cheville, R Houston Thompson, et al.
European Urology|June 6, 2015
Comprehensive Characterization of the Perioperative Morbidity of Cytoreductive NephrectomyBoris Gershman, Daniel M Moreira, Stephen A Boorjian, et al.
The Journal of Urology|March 26, 2018
Comparative Survival following Initial Cytoreductive Nephrectomy versus Initial Targeted Therapy for Metastatic Renal Cell CarcinomaBimal Bhindi, Elizabeth B Habermann, Ross J Mason, et al.
European Urology|January 18, 2017
Renal Cell Carcinoma with Isolated Lymph Node Involvement: Long-term Natural History and Predictors of Oncologic Outcomes Following Surgical ResectionBoris Gershman, Daniel M Moreira, R Houston Thompson, et al.
European Urology|November 15, 2017
Perioperative Morbidity of Lymph Node Dissection for Renal Cell Carcinoma: A Propensity Score-based AnalysisBoris Gershman, Daniel M Moreira, R Houston Thompson, et al.
The Journal of Urology|September 25, 2016
Lymph Node Dissection is Not Associated with Improved Survival among Patients Undergoing Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: A Propensity Score Based AnalysisBoris Gershman, R Houston Thompson, Daniel M Moreira, et al.
Pageof 12